Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Blood Sampling Strategies and Treatment Outcomes of Anticancer Drugs
NL-OMON61392Recruiting
- Sponsor
- Netherlands Cancer Institute
- Start
- Oct 2026
- Countries
- 1
01
Overview
Open-label, single-arm trial in cancer, sponsored by Netherlands Cancer Institute. Primary endpoint: Feasibility of managing blood sample logistics both at home and across multiple hospitals throughout the Netherlands. Started Oct 2026; status: recruiting.
02
Conditions
cancer
Beyond the preview
Go deeper on NL-OMON61392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON61392.